Aposave Limited was born in 2013 with the vision of providing affordable access to critical medicines. Our focus is on specialty medicines and orphan drugs that are manufactured for various conditions. Conditions such as (but not limited to): Cancer, Crohn’s Disease, Diabetes, Hepatitis C, HIV, Multiple Sclerosis, Parkinson’s Disease and Psoriasis.
Originally, Aposave traded solely as an online NHS pharmacy and a trusted provider of specialty medicines for private prescriptions in the United Kingdom. The company decided to focus on a targeted group of patients interested in bypassing the NHS and obtaining fast access to newly-registered medicines.
When we started
The company’s founding location in London serves as our global headquarters – a GPhC licensed pharmacy in the center of London. From the very moment that we began trading, we noticed that the majority of our patients were located outside of the United Kingdom and European Union.
A major factor for this statistic is that European countries have the bargaining power to sit down with the manufacturers to negotiate drug pricing. This contributes to creating significant cost savings on European medicines compared to many other countries (e.g. United States).
We keep on growing
In 2015, we obtained an MHRA wholesale dealer’s license (WDL). Our GDP compliant warehouse is positioned strategically alongside Heathrow Airport. We have been servicing both public & private entities with European medicines ever since.
In 2016, Aposave Asia Limited was born in Hong Kong – our first international subsidiary. Aposave Asia serves as the sales hub for our Asian operations. As such, we are now present with a sales office located in the Central district of Hong Kong and a WDL from the Hong Kong Department of Health. We maintain both ambient and cold chain warehouses in multiple locations.
In December 2017, Aposave was acquired by Abacus Medicine and began functioning as the export division of the company. Abacus Medicine A/S was founded in 2004 and is a distributor of branded, specialty medicines. Abacus Medicine has become one of Europe’s fastest-growing distributors of specialty medicine and holds over 2500 marketing authorizations in the European Union. Being a part of the Abacus Medicine group of companies allows us to have one of the strongest supply networks in the world, containing more than 260 active QA-approved EU and US suppliers. This enables Aposave to access and deliver these critical medicines in the most expedient manner. To learn more about Abacus Medicine, please visit its website here: www.abacusmedicine.com
Aposave is a global healthcare enterprise who is always on the
lookout for talented and like-minded individuals.
If you are interested in learning more about Aposave and its
current job openings, follow the link below to get in touch!
You can also follow us on LinkedIn
We are there for you
Contact our global support at any time. We are standing by to assist you with all questions..
Get in touch
Write us an email. We will get back to you within 24 hours during business hours.
Follow us on LinkedIn for company news.